Case Report
References
|
Bahr GM, Tribonnière DLX, Darcissac E, Ajana F, Bocket L, Sissoko D, Yazdanpanah Y, Dewfulf J, Amiel C, Mouton Y (2003). Clinical and immunological effects of a 6-week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment. Journal of Antimicrobial Chemotherapy 51:1377-1388. |
|
|
Catwaba KJ, Mutate B, Kashia D, Wembonyama S (2017). Causes of deaths of HIV infected patients at the HIV/AIDS Center of Excellence of the University of Lubumbashi in Lubumbashi, Democratic Republic of Congo. Journal of Infectious Diseases and Medicine 2:3. |
|
|
Centers for Disease Control and Prevention (1994). The Morbidity and Mortality Weekly Report. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age 43(12):1-10. |
|
|
Edmonds A, Yotebieng M, Lusiama J and Behets F (2012). Quantification of CD4 Responses to Combined Antiretroviral Therapy Over 5 Years Among HIV-Infected Children in Kinshasa, Democratic Republic of Congo. Journal of Acquired Immune Deficiency Syndromes 61(1):90-98. |
|
|
Garrido C, Abad-Fernandez M, Tuyishime M, Pollara JJ, Ferrari G, Soriano-Sarabia N, Margolis DM. (2018). Interleukin-15-stimulated natural killer cells clear HIV-1-infected cells following latency reversal ex vivo. Journal of Virology 92:00235 |
|
|
Goldfarb RH, Herberman RB (1982). Characteristics of natural killer cells and possible mechanisms for their cytotoxic activity. Advances in Inflammation Research 4:45 72. |
|
|
Gontran M, Jerome LT, Yvonne AM, Mavoungou-Poaty V, Elie M, Brice O, Donatien M (2009). Effects of IM28 on HIV-1 and metabolic disorders-induced highly active antiretroviral therapy in Gabonese patients. Journal of Antivirals and Antiretrovirals 1:076-081. |
|
|
Grassetti DR, Moro C (2013). European patent specification. Method of immunomodulation using thione-forming disulfides EP1383499B1. |
|
|
Grassetti DR, Moro C (2012). Method of immunomodulation using thione-forming disulfides. United States Patent No.US (8)163:776 BS |
|
|
Grassetti DR (1970). Effect of 6,6-ditiodinicotinic acid on the dissemination of Ehrlich ascites tumor. Nature 5258(228):282-83. |
|
|
Grassetti DR (1986). The antimetastatic and tumor growth retarding effects of sulfur containing analogs of nicotinamide. Cancer Letters 31:187-195. |
|
|
Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD (1996). Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable no progressing HIV type 1 infection. AIDS research and humans retroviruses 12(7):585-592. |
|
|
Martrus G, Altfeld M (2016). Immunological strategies to target HIV persistence. Current Opinion in HIV-AIDS 11(4):402-408. |
|
|
Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, O'Shea MA, Kinter A, Kovacs C, Moretta A, Fauci AS (2005). Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected vermeil individuals. Proceedings of the National Academy of Sciences USA. 102(8):2886-2891. |
|
|
Mikulak J, Oriolo F, Zaghi E, Di Vito C, Mavilio D (2017). Natural Killer cells in HIV-1 infection and therapy. AIDS 31(17):2317-2330 |
|
|
Minister of Health, DRC/Programme National de lutte contre le SIDA (PNLS) (2004). Guide pratique des prestataires de prévention de la transmission du VIH de la mère à l'enfant, Ministère de la Santé Publique, DRC, Kinshasa, DRC. |
|
|
Ndarabu A, Mbombo W, Mulumba P, Mbuyi D, Tshilolo L (2017). Trial of immunotherapy in HIV patients: our experience with the immuno-modulator dithiodinicotinic Acid (CPDS) in 34 Congolese patients. The Global Journal of Medical Research 17:2. |
|
|
Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F (2004). Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: A pooled analysis. The Lancet 364(9441):1236-1243. |
|
|
Nishimura Y, Gautam R, Chun TW, Sadiadpour R, Foulds KE, Shingai M, Gazumyan A, Gollianin J, Donaldson M, Donau OK, Plishka RJ, Buckler-White A, Seaman MS, Lifson JD, Koup RA, Fauci AS, Nussenzweig MC, Martin MA (2017), Early antibody therapy can induce long lasting immunity to shiv. Nature 543(7646):559-563 |
|
|
Scully E, Alter G (2016). NK cells in HIV disease. Current HIV/AIDS Reports 13(2):85-94. |
|
|
Tomin K, Goldfarb RH, Albertsson P (2016). In Vitro Assessment of Human Natural Killer Cell Migration and invasion. : Natural Killer Cells: Methods and Protocols, Methods in Molecular Biology 1441:65-74. |
|
|
United Nations Programme on HIV and AIDS (UNAIDS) (2017). Data |
|
|
United Nations Programme on HIV and AIDS (UNAIDS) (2016). Fast Track commitments to end AIDS by 2030 |
|
|
Weiser SD, Palar K, Frongillo EA, Tsai AC, Kumbakumba E, dePee S, Hunt PW, Ragland K, Martin J, Bangsberg DR (2013). Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda. AIDS 28(1):115-120. |
|
|
Williams BG, Lima V, Gouws E (2011). Modeling the impact of Antiretroviral Therapy on the Epidemic of HIV. Current HIV Research 9(6):367-382. |
|
|
World Health Organization (1990). Interim proposal for a WHO Staging System for HIV infection and disease. Weekly Epidemiological Record 65(29). |
|
|
Yotebieng M, Rie AV, Luisiama J, Behets F (2010). Survival, clinical, immunological and hematological outcomes of antiretroviral therapy among HIV-infected children attending a public clinic in Kinshasa, Democratic Republic of Congo. International Journal of Infectious Diseases 14(1). |
|
|
Zhang J, Crumpacker C (2013). Eradication of HIV and cure of AIDS, Now and How? Frontiers in Immunology 4:337. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
